|
|||||
       |
(National Renewable Energy Laboratory) The Timken Company in Canton, Ohio revealed plans for a new research and development center for wind turbine mechanisms used to generate electricity. The $11.8 million facility, built in collaboration with nearby Stark State College, is expected to add 65 new jobs. The R&D center will focus on wind . . . → Read More: Timken, College to Build Wind Energy R&D Center  Comments are closed  Finance, Hiring/layoffs, Joint ventures/collaborations  cleantech, debt, energy, engineering, grant, investment, manufacturing, physical sciences, university (Photos8.com) Here are recent angel and venture finance transactions for science- and engineering-based companies, as reported by Xconomy and elsewhere. Biomedical/Life Sciences Rosetta Genomics Ltd. in Philadelphia, Pennsylvania. MicroRNA-based molecular diagnostics. $6.0 million, equity. Versartis in Mountain View, California. Protein drugs for endocrine disorders. $21 million in Series B equity financing. Ivivi Health . . . → Read More: Finance Friday: 18 February 2011 2 comments - (Comments are closed) Finance biotechnology, cleantech, debt, energy, entrepreneurs, equity, investment, life sciences, medical device, pharmaceuticals, venture capital (Photos8.com) Here are recent financial transactions for science- and engineering-based companies reported by Xconomy. Biomedical/Life Sciences AcelRx Pharmaceuticals in Redwood City, California. Pain medications. $40 million IPO: 8 million shares @ $5.00. Optimer Pharmaceuticals in San Diego, California. Antibiotics. $67.5 million stock offering: 6 million shares @ $11.25. Fluidigm in South San Francisco, . . . → Read More: Finance Friday: 11 February 2011 (Photos8.com) Here are recent angel and venture finance transactions for science- and engineering-based companies reported by Xconomy. Biomedical/Life Sciences Meritage Pharma in San Diego, California. Specialty drug discovery and development. $2 million, equity. XDx in Brisbane, California. Molecular diagnostics. $12.5 million, debt (from GE Capital) Stromedix in Cambridge, Massachusetts. Specialty drug discovery and . . . → Read More: Finance Friday: 28 January 2011 (Photos8.com) Here are recent angel and venture finance transactions for science- and engineering-based companies reported by CB Insights … Biomedical/Life sciences Fluidigm in South San Francisco, California. Medical devices and equipment. $5 million, debt Cognition Therapeutics in Pittsburgh, Pennsylvania. Discovery and development of small molecule therapeutics. $2.5 million, series A equity Adhezion Biomedica . . . → Read More: Finance Friday: 21 January 2011 The Office of the Comptroller of the Currency (OCC), an agency of the U.S. Department of the Treasury, reports today that its annual survey of banks’ credit underwriting standards — guidelines for issuing loans — found that commercial credit standards remained tight for the 12-month period ending on 31 March 2010. Credit standards for small . . . → Read More: Treasury Dept: Commercial Credit Standards Tightening Pacific Biosciences in Menlo Park, California, a developer of molecular biology technology, announced completion of a new round of financing worth $109 million. This round includes a previously announced $50 million investment by Gen-Probe Inc., a maker of molecular diagnostic products and services. Hugh Martin, Pacific Biosciences’s chairman and CEO says the funding will be . . . → Read More: Financing Deals: 14 July 2010 |
||||
|
Copyright © 2024 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
RSS - Posts
You must be logged in to post a comment.